Mallinckrodt PLC (MCKPF)
0.12
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Mallinckrodt Revenue (Quarterly): 505.50M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 505.50M |
June 30, 2024 | 514.30M |
March 31, 2024 | 467.80M |
September 30, 2023 | 497.00M |
June 30, 2023 | 475.00M |
March 31, 2023 | 424.60M |
December 31, 2022 | 489.30M |
September 30, 2022 | 550.40M |
June 30, 2022 | 383.70M |
March 31, 2022 | 490.90M |
December 31, 2021 | 597.20M |
September 30, 2021 | 507.20M |
June 30, 2021 | 546.40M |
March 31, 2021 | 558.00M |
December 31, 2020 | 682.80M |
September 30, 2020 | 698.30M |
June 30, 2020 | 166.50M |
March 31, 2020 | 665.80M |
December 31, 2019 | 804.90M |
September 30, 2019 | 743.70M |
June 30, 2019 | 823.30M |
March 31, 2019 | 790.60M |
December 31, 2018 | 834.90M |
September 30, 2018 | 799.90M |
June 30, 2018 | 825.50M |
Date | Value |
---|---|
March 31, 2018 | 755.30M |
December 31, 2017 | 1.461B |
September 30, 2017 | 600.60M |
June 30, 2017 | 824.50M |
March 31, 2017 | 810.90M |
December 31, 2016 | 829.90M |
September 30, 2016 | 577.40M |
June 30, 2016 | 970.60M |
March 31, 2016 | 918.00M |
December 31, 2015 | 811.20M |
September 30, 2015 | 459.50M |
June 30, 2015 | 877.30M |
March 31, 2015 | 819.00M |
December 31, 2014 | 768.20M |
September 30, 2014 | -100.80M |
June 30, 2014 | 653.10M |
March 31, 2014 | 557.80M |
December 31, 2013 | 540.20M |
September 30, 2013 | 53.00M |
June 30, 2013 | 570.00M |
March 31, 2013 | 585.30M |
December 31, 2012 | 504.00M |
September 30, 2012 | 513.10M |
June 30, 2012 | 516.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
166.50M
Minimum
Jun 2020
804.90M
Maximum
Dec 2019
527.66M
Average
507.20M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
Alkermes PLC | 378.14M |
Jazz Pharmaceuticals PLC | 1.055B |
Medtronic PLC | 8.403B |
Perrigo Co PLC | 1.088B |
Iterum Therapeutics PLC | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -26.20M |
Total Expenses (Quarterly) | 453.80M |
EPS Diluted (Quarterly) | -1.33 |
Enterprise Value | 1.332B |
Gross Profit Margin (Quarterly) | 43.74% |
Profit Margin (Quarterly) | -5.18% |
Earnings Yield | -112.9K% |
Operating Earnings Yield | 3.89K% |
Normalized Earnings Yield | -33236.26 |